The top news stories in medicine this week.

Ballard Spahr says the Hikma v. Amarin decision makes it harder for brand-name drugmakers to sue over "skinny label" generics — a shift likely to speed generic competition and lower costs for patients

In a University of Toronto simulation, AI scribes cut documentation from 36.3% of each primary care visit to 11.2%, though total visit length didn’t change significantly.

A study published in Advanced Science used three AI models to screen thousands of approved drugs, identifying nine that inhibit Streptococcus pneumoniae, a bacterium increasingly resistant to antibiotics.

Federal contracts, Medicare pilots and new state laws have pushed artificial intelligence from the edges of clinical practice into the middle of it.

New national research shows health systems and health plans still can't get provider data right — and the fallout lands squarely on physician practices

Kansas court records reviewed by The New York Times show the practice charged 18% annual interest, garnished bank accounts and pursued arrest warrants over balances as small as $101.

RFK Jr. appoints members to fill a panel that has not met in more than a year, but is influential on primary care.